Global Methotrexate Injection Market, By Disease Type (Leukaemia, Psoriasis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Vasculitis, Reactive Arthritis, Localised Scleroderma, Uveitis, Lupus (SLE), Juvenile Dermatomyositis, Others), Drug Type (Branded, Generics), Population (Adults, Paediatric, Others), Route of Administration (Intramuscular, Subcutaneous, Others), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.
Methotrexate Injection Market Analysis and Size
Major factors that are expected to boost the growth of the global methotrexate injection market in the forecast period 2023-2030 are the rise in the global burden of target diseases. Furthermore, the increase in product commercialization and the growth in investments to encourage product development are further anticipated to propel the growth of the global methotrexate injection market.
Data Bridge Market Research analyses that the global methotrexate injection market which was USD 527.52 million in 2022, is expected to reach USD 687.65 million by 2030, and is expected to undergo a CAGR of 2.6% during the forecast period 2023-2030. “Leukemia” dominates the type segment of the market owing to the increasing prevalence of diseases among the population. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Methotrexate Injection Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Disease Type (Leukaemia, Psoriasis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Vasculitis, Reactive Arthritis, Localised Scleroderma, Uveitis, Lupus (SLE), Juvenile Dermatomyositis, Others), Drug Type (Branded, Generics), Population (Adults, Paediatric, Others), Route of Administration (Intramuscular, Subcutaneous, Others), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa
|
|
Market Players Covered
|
Cumberland Pharmaceuticals Inc. (U.S.), Medexus Pharmaceuticals, Inc. (Canada), Teva Pharmaceutical Industries Ltd. (Israel), LUPIN (India), Hikma Pharmaceuticals PLC (U.K.), Alkem Labs Ltd. (India), PRAGMA therapeutics (France), Sandoz AG (Switzerland), GlaxoSmithKline Plc. (India), Par Pharmaceutical Ltd. (U.S.), Amneal Pharmaceutical Inc. (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Dr. Reddy's Laboratories (India), Aurobindo Pharma Limited (India), Perrigo Company plc (Ireland), Akron Inc (U.S.), Cosette Pharmaceuticals (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Certain types of cancer, autoimmune disorders, and ectopic pregnancies are just a few ailments routinely treated using the drug methotrexate. It is a member of the medication class known as antimetabolites, which slows down the division of cells that divide quickly. There are several ways to deliver methotrexate, including subcutaneous injection, intravenous (IV) infusion, and oral tablet form. The subcutaneous injection form will be the main emphasis of this article.
Global Methotrexate Injection Market Dynamics
Drivers
- Increasing Prevalence of Diseases
Worldwide prevalence continues to be high for diseases like rheumatoid arthritis, psoriasis, and cancer. The demand for methotrexate injections as a part of treating these disorders is projected to rise as their incidence and prevalence increase, creating a potential opportunity for the market.
- Increasing R&D Activities
The market may advance thanks to ongoing research & development initiatives aimed at discovering new methotrexate therapeutic applications and creating inventive formulations or combination medicines.
- Increasing Geriatric Population
Rheumatoid arthritis and several malignancies are among the chronic diseases that are linked to an increased risk in the aging population. The need for efficient therapies for these ailments is increasing as the world's population ages, which may increase the need for methotrexate injections.
Opportunities
- Increasing Healthcare Expenditure
The market for methotrexate injections may expand due to increasing healthcare spending and infrastructure improvements, particularly in emerging nations.
- Rising Technological Advancements
Methotrexate injections can be made more convenient, safe, and patient-compliant with the help of improvements in drug delivery systems and injectable technologies. The patient experience can be enhanced and opportunities for differentiation can be presented by better equipment, such auto-injectors and wearable injectors.
- Increasing Demand for Personalized Medicine
Personalising medical care for each patient based on their unique features is an idea that is gaining ground. Methotrexate injections can be included in individualized treatment plans, and as the use of precision medicine methods increases, there might be chances to improve dosage methods and improve outcomes.
Restrains/ Challenges
- Strict Regulatory Guidelines
The arrival of methotrexate injections onto the market and their accessibility can be impacted by the complex and drawn-out process of complying with regulatory regulations and receiving regulatory bodies' approvals. Players in the market may face difficulties due to strict rules relating to drug safety, manufacturing procedures, and labeling.
- Adverse Effects and Safety Concerns
The use of methotrexate injections carries several risks and potential negative effects. Safety issues and reports of unfavorable events could undermine patient acceptance and intensify regulatory scrutiny, thereby limiting market expansion.
- Limited Reimbursement and Coverage Policies
The availability and cost of methotrexate injections can be considerably impacted by pricing and reimbursement policies. Market entry and income creation may be hampered by negotiations with payers and healthcare systems, as well as by differing regional reimbursement rates.
- Patient Adherence and Compliance
Regular administration of methotrexate injections and adherence to recommended treatment regimens are frequently needed. Poor patient compliance can have an impact on treatment results and make it difficult for manufacturers and healthcare professionals to ensure that the drug is taken as prescribed.
This global methotrexate injection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global methotrexate injection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Methotrexate Injection Market Scope
The global methotrexate injection market is segmented on the basis of disease type, drug type, population, route of administration, end-users, and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target market.
Disease Type
- Leukaemia
- Psoriasis
- Rheumatoid Arthritis
- Juvenile Rheumatoid Arthritis
- Vasculitis
- Reactive Arthritis
- Localised Scleroderma
- Uveitis
- Lupus (SLE)
- Juvenile Dermatomyositis
- Others
Drug Type
- Branded
- Generics
Population
- Adults
- Pediatrics
- Others
Route of Administration
- Intramuscular
- Subcutaneous
- Others
End-Users
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Direct Tender
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Global Methotrexate Injection Market Analysis/Insights
The global methotrexate injection market is analyzed and market size insights and trends are provided by country, disease type, drug type, population, route of administration, end-users, and distribution channel as referenced above.
The countries covered in the global methotrexate injection market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the global methotrexate injection market due to the presence of high healthcare expenditure and research & development. Europe accounts for the second largest market share due to increased research & development and the presence of refined medical facilities.
Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period of 2023 to 2030 due to increased technological advancement, growing healthcare expenditure, and rising awareness program.
The country section of the global methotrexate injection market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. The global methotrexate injection market is analysed and market size insights and trends are provided by country, product, indication and end user as referenced above.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global methotrexate injection market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global methotrexate injection market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on global methotrexate injection market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Methotrexate Injection Market Share Analysis
The global methotrexate injection market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points are only related to the companies’ focus on the global methotrexate injection market.
Some of the major players operating in the global methotrexate injection market are:
- Cumberland Pharmaceuticals Inc. (U.S.)
- Medexus Pharmaceuticals, Inc. (Canada)
- Teva Pharmaceutical Industries Ltd. (Israel)
- LUPIN (India)
- Hikma Pharmaceuticals PLC (U.K.)
- Alkem Labs Ltd. (India)
- PRAGMA therapeutics (France)
- Sandoz AG (Switzerland)
- GlaxoSmithKline Plc. (India)
- Par Pharmaceutical Ltd. (U.S.)
- Amneal Pharmaceutical Inc. (U.S.)
- Mylan N.V. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Dr. Reddy's Laboratories (India)
- Aurobindo Pharma Limited (India)
- Perrigo Company plc (Ireland)
- Akron Inc (U.S.)
- Cosette Pharmaceuticals (U.S.)
SKU-